PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

A third of UK doctors have treated COVID-19 patients without full PPE, report finds

A new report has found that more than a third of UK doctors have treated COVID-19 patients in person without sufficient personal protective equipment (PPE) during th...
Continue Reading →
News

ICR study combines precision medicines to treat drug-resistant cancers

Results from an early-stage trial demonstrate that using a combination of two precision medicines to target hard-to-treat cancers was safe and showed promise in a ra...
Continue Reading →
News

Sleep apnoea linked to poorer outcomes from COVID-19, study finds

A systematic review of studies by researchers at the University of Warwick has found that people who have been diagnosed with obstructive sleep apnoea could be at an...
Continue Reading →
News

A COVID-19 vaccine in early November? ‘Extremely unlikely, but not impossible’: Warp Speed head Slaoui

With COVID-19 vaccine hype intensifying each day—including this week, with new comments from Pfizer’s CEO—the head of the U.S. government’s research progra...
Continue Reading →
News

Akebia crashes on vadadustat flop in larger anemia indication. Will AZ, FibroGen own the market?

What was previously expected to be a three-way battle in the novel HIF-PHI renal anemia drug class now has one man down. Akebia Therapeutics has posted a surpri...
Continue Reading →
News

Roche, Blueprint take on Lilly with FDA approval for RET cancer drug Gavreto

It was only May when Eli Lilly’s Retevmo became the first FDA-approved drug for RET-altered tumors. Now, a rival therapy has arrived with the marketing clout of...
Continue Reading →
News

CSL plots millions of doses of COVID-19 vaccine shots, including AstraZeneca’s, for Aussie government

Looking to secure enough doses of a COVID-19 vaccine frontrunner for its residents, the Australian government signed an expansive supply deal with British drugm...
Continue Reading →
News

Former FDA Commissioner Dr. Scott Gottlieb to address industry on sustainable innovation at CPhI Festival of Pharma

Two-week programme to spark first pan-global debate on pharma’s 2020 transformations underway. Sessions will cover affordable medicines, ultra-rapid innovation, supp...
Continue Reading →
News

UK launch for Novo’s new diabetes pill

Novo Nordisk has launched in the UK the first 'protein in a pill' treatment for type II diabetes. Rybelsus (semaglutide tablets) is the world’s first and only oral...
Continue Reading →
News

Kevzara fails in PhIII COVID-19 trial

Sanofi and Regeneron's rheumatoid arthritis drug Kevzara (sarilumab) has failed to hit targets in a late-stage trial involving patients hospitalised with COVID-19, s...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026